Online citations, reference lists, and bibliographies.

Cystic Hygroma And Lymphatic Malformations

Shigeru Ono
Published 2018 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Lymphatic malformations (LMs) are uncommon congenital low-flow vascular anomalies previously referred to as lymphangiomas or cystic hygromas. The terminology of vascular and lymphatic lesions needs to be standardized. Vascular and lymphatic lesions, in general, have been notoriously difficult for pathologists to diagnose and classify because of the large number of entities and their variants, and their frequently overlapping clinical and histopathologic features. This problem has been compounded by imprecise terminology with various names referring to the same lesion or, conversely, a particular term denoting different entities. Recently, the International Society for the Study of Vascular Anomalies (ISSVA), an organization comprised of specialists in various disciplines interested in vascular anomalies, approved a novel classification of vascular lesions that distinguishes malformations from tumors and provides an easily understood and concise nomenclature.
This paper references
10.1016/j.ijporl.2008.03.013
Utility of radiofrequency ablation for haemorrhagic lingual lymphangioma.
N. Leboulanger (2008)
10.1055/B-0034-84970
Vascular Anomalies of the Head and Neck
R. Wetmore (2012)
10.1007/s00270-002-1980-3
Treatment of Lymphangiomas with OK-432 (Picibanil)
R. Rautio (2002)
10.1016/j.jcms.2012.10.022
Pingyangmycin with triamcinolone acetonide effective for treatment of lymphatic malformations in the oral and maxillofacial region.
Q. Luo (2013)
10.1056/NEJMc1112482
Sildenafil for severe lymphatic malformations.
Glenda L. Swetman (2012)
10.1177/153857440503900107
Current Concepts in Lymphatic Malformation
B. Lee (2005)
10.1016/S0022-3468(96)90478-9
OK-432 therapy for lymphangioma in children: why and how does it work?
S. Ogita (1996)
10.1016/j.ijporl.2008.08.003
Low power radiofrequency ablation for symptomatic microcystic lymphatic malformation of the tongue.
N. Ryu (2008)
10.1016/J.JOMS.2004.04.024
Surgical management of lymphangiomatous or lymphangiohemangiomatous macroglossia.
X. Jian (2005)
10.1016/S0022-3468(86)80077-X
Infections of congenital cervical neck masses associated with bacteremia.
T. Wiswell (1986)
10.1016/j.otohns.2010.02.026
Lymphatic malformations: Review of current treatment
J. Perkins (2010)
10.1016/j.otohns.2008.02.016
Clinical and radiographic findings in children with spontaneous lymphatic malformation regression
J. Perkins (2008)
10.1007/s00405-001-0438-6
OK-432 (Picibanil) therapy for lymphangiomas in children
J. Laranne (2001)
10.7863/jum.2006.25.11.1437
Prenatal Diagnosis of Fetal Chest Lymphangioma
I. Goldstein (2006)
10.1016/0022-3468(91)90500-S
OK-432 therapy for unresectable lymphangiomas in children.
S. Ogita (1991)
10.1016/S0146-0005(99)80042-1
Cystic hygroma in the fetus and newborn.
P. Gallagher (1999)
10.1016/S0022-3468(99)90168-9
Long-term follow-up of nineteen cystic lymphangiomas treated with fibrin sealant.
M. Castañón (1999)
10.1016/0022-3468(92)90316-Y
Complications of lymphangiomas in children.
B. J. Hancock (1992)
10.1007/s00383-003-1058-6
Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations
T. Muir (2004)
10.1097/01.RVI.0000239104.78390.E5
Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement.
A. Al-Omari (2006)
10.1002/1097-0142(19870815)60:4<741::AID-CNCR2820600406>3.0.CO;2-2
Treatment of cystic hygroma and lymphangioma with the use of bleomycin fat emulsion
N. Tanigawa (1987)
Vascular tumors and vascular malformations (new issues).
O. Enjolras (1997)
10.3748/WJG.V10.I17.2588
Chylous ascites: treated with total parenteral nutrition and somatostatin.
Q. Huang (2004)
10.1148/RADIOLOGY.204.3.9280239
Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.
Jorge Gutiérrez Dubois (1997)
10.1007/BF02283890
Chylous ascites
L. Donald Weinstein (1969)
10.1016/J.OCL.2006.04.005
Classification, diagnosis, and interventional radiologic management of vascular malformations.
G. Legiehn (2006)
10.1016/j.ijporl.2009.04.016
Management of lymphatic malformations and macroglossia: results of a national treatment survey.
D. Bloom (2009)
10.1067/MSY.2000.109502
Chylous ascites: a collective review.
O. O. Aalami (2000)
Traitement non chirurgical des lymphangiomes kystiques
M. Riché (1986)
10.1001/ARCHOTOL.1996.01890230041009
OK-432 therapy for lymphangiomas.
R. Smith (1996)
10.1097/00005176-198508000-00031
Chylous ascites in infants and children: a case report and literature review.
W. J. Cochran (1985)
10.1016/j.jpedsurg.2007.09.049
Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities.
W. Shiels (2008)
10.3233/NPM-1365712
Giant neonatal thoraco-abdominal lymphatic malformations treated with sildenafil: a case report and review of the literature.
P. Singh (2013)
10.1001/archoto.2010.6
Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy.
S. J. Boardman (2010)
10.1097/00005537-200410000-00024
OK‐432 Therapy for Cervical Lymphangioma
J. Sichel (2004)
10.1056/NEJM198310063091403
Fetal cystic hygroma. Cause and natural history.
F. Chervenak (1983)
10.1159/000440939
Lymphatic Malformation in Newborns as the First Sign of Diffuse Lymphangiomatosis: Successful Treatment with Sirolimus
N. Laforgia (2015)
10.1016/0022-3468(92)90331-Z
Injection of bleomycin as a primary therapy of cystic lymphangioma.
A. Okada (1992)
10.1001/ARCHOTOL.128.10.1137
Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial.
C. M. Giguere (2002)
10.1016/j.jpedsurg.2010.06.010
OK-432 therapy for chylous pleural effusion or ascites associated with lymphatic malformations.
S. Ono (2010)
10.1016/j.ijporl.2008.10.022
Bipolar radiofrequency plasma ablation (Coblation) of lymphatic malformations of the tongue.
Soham Roy (2009)
10.1007/s00595-013-0806-z
A new operative strategy for refractory microcystic lymphangioma
S. Ono (2013)
10.1016/S0022-3468(98)90589-9
Prenatally diagnosed cystic lymphangioma in infants.
N. Suzuki (1998)
10.1016/S0022-3468(74)80120-X
Cystic hygroma in children: a report of 126 cases.
Tràn Ngoc Ninh (1974)
10.1016/J.JPEDSURG.2006.10.012
Treatment of lymphangioma in children: our experience of 128 cases.
T. Okazaki (2007)
10.1002/pbc.24866
Treatment of a tongue lymphangioma with sirolimus after failure of surgical resection and propranolol.
C. Akyüz (2014)
10.1089/15396850360495664
The second valve system in lymphatics.
G. W. Schmid-Schönbein (2003)
10.1007/s004640080025
Initial results with an electrothermal bipolar vessel sealer
B. Heniford (2009)
10.1542/peds.2014-3673
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
M. Wassef (2015)
10.1378/CHEST.117.3.902
Conservative treatment of postsurgical lymphatic leaks with somatostatin-14.
J. Collard (2000)
10.1002/bjs.1800740812
Intracystic injection of OK‐432: A new sclerosing therapy for cystic hygroma in children
Dr. S. Ogita (1987)
10.1016/0022-3468(94)90370-0
OK-432 therapy in 64 patients with lymphangioma.
S. Ogita (1994)
10.1620/TJEM.229.61
Propranolol as an alternative treatment option for pediatric lymphatic malformation.
M. Ozeki (2013)
10.1097/SCS.0b013e3181abb249
Treatment of Lymphatic Malformations With OK-432 (Picibanil): Review of the Literature
M. Poldervaart (2009)
10.1016/0022-3468(95)90485-9
Bleomycin therapy for cystic hygroma.
J. Orford (1995)
10.1002/1097-0096(200102)29:2<112::AID-JCU1009>3.0.CO;2-Q
Prenatal sonographic diagnosis of axillary cystic lymphangiomas
S. Zanotti (2001)



Semantic Scholar Logo Some data provided by SemanticScholar